United States· US:71475-258_2dd1af4c-76f8-d933-e063-6394a90a3931
Kodatef
A tafenoquine product containing tafenoquine, registered in United States by 60 Degrees Pharmaceuticals, INC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TAFENOQUINE
- Manufacturer
- 60 Degrees Pharmaceuticals, INC
- Country
- United States (US)
- ATC code
- P01BA07
- ATC class
- Tafenoquine
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1171475258031 TABLET, FILM COATED in 1 CARTON (71475-258-03)
- ndc1171475-258-03
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
31 interactions on record for tafenoquine.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tafenoquine · interactions on record
31 records
- 2 severe
- 29 moderate
Most severe, free to view
- DofetilideC01BD04severe
- PrilocaineN01BB04severe
- LidocainA01AE01moderate
- TetracainA01AE02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under P01BA07
Tafenoquine, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf142a13-ae84-4d2d-8306-19958a2c19ff GET /v1/drugs/bf142a13-ae84-4d2d-8306-19958a2c19ff?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "100",
"substance": "TAFENOQUINE",
"productndc": "71475-258",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE"
}See everything about tafenoquine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.